Pharmacotherapy of social anxiety disorder

Biological Psychiatry

Volumn 51, Issue 1, 2002, Pages 109-120

  Blanco, Carlos ^a,b   Antia, Smita X ^a,b   Liebowitz, Michael R ^a,b  

^a Columbia College of Physicians and Surgeons ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Anxiety disorders; Monoamine oxidase inhibitors; Pharmacotherapy; Serotonin reuptake inhibitors; Social anxiety disorder; Social phobia

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROFAROMINE; BROMAZEPAM; BUSPIRONE; CITALOPRAM; CLONAZEPAM; FLUOXETINE; FLUVOXAMINE; GABAPENTIN; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; PHENELZINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ANXIETY NEUROSIS; CLINICAL TRIAL; COMORBIDITY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; HUMAN; PREDICTION; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RELAPSE; REMISSION; REVIEW; SIDE EFFECT; SOCIAL PHOBIA; TREATMENT OUTCOME;

HUMANS; MONOAMINE OXIDASE INHIBITORS; PHOBIC DISORDERS; SEROTONIN UPTAKE INHIBITORS;

EID: 0036153567     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(01)01294-X     Document Type: Review

References (53)

1. Paroxetine in social anxiety disorder: A randomized placebo-controlled study
2. Paroxetine in social phobia/social anxiety disorder: Randomized, double blind, placebo-controlled study
3. Fluoxetine for the treatment of social phobia
4. Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia
5. The epidemiology of social phobia: Findings from the Duke epidemiological catchment area study
6. Treatment of social phobia with clonazepam and placebo
7. Treatment of social phobia with bupropion
8. Social phobia: The clinical efficacy and tolerability of the monoamine oxidase-A and serotonin uptake inhibitor brofaromine
9. Cognitive behavioral and pharmalogical treatment of social phobia: A controlled study
10. Cognitive behavioral group treatment of social phobia: Comparison to a credible placebo control
11. Cognitive-behavioral group therapy versus phenelzine in social phobia: 12-week outcome
12. Moclobemide in social phobia. A double blind, placebo-controlled clinical study
13. Sertraline for social phobia: A double-blind, placebo-controlled crossover study
14. Social phobia
15. Cognitive-behavioral group therapy versus phenelzine in social phobia: Long-term outcome
16. Phenelzine versus imipramine in atypical depression: A preliminary report
17. Phenelzine vs. atenolol in social phobia: A placebo-controlled comparison
18. Brofaromine for social phobia: A multicenter, placebo-controlled, double-blind study
19. Different ages of onset in varieties of phobias
20. Brief standard self-rating for phobic patients
21. A clinical trial of phenelzine in anxiety depressive and phobic neuroses
22. A pilot study of buspirone in the treatment of social phobia
23. Antianxiety effects of MAO inhibitors
24. Moclobemide in social phobia: A controlled dose-response trial
25. Treatment of social phobia with gabapentin: A placebo-controlled study
26. Pharmacological treatments: Literature review
27. Fluvoxamine for the treatment of anxiety disorders in children and adolescents
28. Fluoxetine in social phobia
29. A placebo-controlled trial of moclobemide in social phobia
30. Social phobia: Comorbidity and morbidity in an epidemiological sample
31. Buspirone in social phobia
32. Behavior therapy versus drug therapy in the treatment of phobic neurosis
33. Phenelzine and exposure in the treatment of phobias
34. Paroxetine in the treatment of generalized social phobia: Open-label treatment and double-blind, placebo-controlled discontinuation
35. Fluvoxamine treatment so social phobia (social anxiety disorder): A double blind, placebo-controlled study
36. Paroxetine treatment of generalized social phobia (social anxiety disorder): A randomized, double-blind, placebo-controlled study
37. Fluoxetine treatment of social phobia
38. Social phobia: A comparison of behavior therapy and atenolol
39. A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety
40. Buspirone augmentation of selective serotonin reuptake inhibitors (SSRIs) in social phobia
41. Sertraline treatment of generalized social phobia: A 20-week, double-blind, placebo-controlled study
42. Psychopharmacological treatment of social phobia: Clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor
43. Psychopharmacological treatment of social phobia: A double blind controlled study with fluvoxamine
44. Clinical effects of buspirone in social phobia: A double-blind placebo-controlled study
45. Tranylcypromine in social phobia
46. Fobia social
47. Double-blind placebo controlled trial with bromazepam in social phobia
48. Pharmacotherapy of social phobia: A controlled study with moclobemide and phenelzine
49. Prevention of relapse in generalized social phobia: Results of a 24-week study in responders to 20 weeks of sertraline treatment
50. Measurement of social evaluation anxiety